ROBERT SING: Open Payments
NPI 1598853301 · SRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,352 in 90 payments from 21 companies in 2025. Trend: 2023 $1,463 · 2024 $1,481 · 2025 $2,352
Food & beverage: $2,352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $391 |
| AstraZeneca Pharmaceuticals LP | 9 | $292 |
| Axsome Therapeutics, Inc. | 16 | $284 |
| Novo Nordisk Inc | 9 | $248 |
| Lilly USA, LLC | 4 | $179 |
| PFIZER INC. | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Collegium Pharmaceutical, Inc. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $91 |
| Ossur Americas, Inc. | 2 | $87 |
Products named: VRAYLAR, Auvelity, FARXIGA, Ozempic, ZEPBOUND, NURTEC ODT, TRINTELLIX, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
